View Press Releases
-
Cambridge Healthtech Institute Announces its 14th Annual Structure-Based Drug Design Event
NEEDHAM, MA - Cambridge Healthtech Institute (CHI) today announced the final agenda for its 14th Annual Structure-Based Drug Design conference to be held on May 21-22, 2014
Feb 5, 2014
-
NonProfitEasy - Helping Nonprofits Focus on Passion, Not Paperwork
ROHERT PARK, CA - NonProfitEasy, a leading database management software solution for small to mid-sized nonprofits, today announces a second round of angel financing.
Feb 4, 2014
-
TriStar Technology Ventures Invests in GenomOncology, Chief Information Officer of MedCare Joins Board
WESTLAKE, OH - GenomOncology, provider of technology and services for the rapid and interactive analysis and interpretation of Next Generation Sequencing (NGS) data, today announced the investment from TriStar Technology Ventures , a healthcare innovation venture firm, as well as the appointment
Feb 4, 2014
-
Major Innovation in Site Feasibility Launched at 2014 Summit for Clinical Operations Executives (SCOPE)
NORWOOD, MA - At this year's annual Summit for Clinical Operations Executives (SCOPE) in Miami, data management and information services provider, Infinata, Inc., will unveil SiteSurvey™, its latest innovation in the company's suite of online data management tools serving the life sciences
Feb 4, 2014
-
NIH’s New Accelerating Medicines Partnership
A Statement from Margaret Anderson, Executive Director, FasterCures on the NIH's New Accelerating Medicines Partnership FasterCures applauds the Accelerating Medicines Partnership , a new initiative launched today by the National Institutes of Health (NIH), 10 biopharmaceutical companies, and several disease-spe
Feb 3, 2014
-
University of Pittsburgh Selects GenomOncology to Support Research Efforts
WESTLAKE, OH - GenomOncology today announced that the University of Pittsburgh has selected GenomOncology's GenomAnalytics™ platform and services to explore and mine the breadth of data that exists in The Cancer Genome Atlas (TCGA) . Cancer is a complex disease of the genome with each tumor h
Feb 3, 2014
-
NHS awards significant cytogenetics tender to OGT
OXFORD, UK - Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics.
Feb 3, 2014
-
Insight Pharma Reports Announces Ocular Disorders: Rising Therapeutics, Technologies, and Devices
NEEDHAM, MA. - Cambridge Healthtech Institute's Insight Pharma Reports announces Ocular Disorders: Rising Therapeutics, Technologies, and Devices. The newly released Insight Pharma Report covers a handful of companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.
Jan 30, 2014
-
Cambridge Healthtech Institute Acquires the Knowledge Foundation Inc.
NEEDHAM, MA - Cambridge Healthtech Institute (CHI) announces today the acquisition of the Knowledge Foundation, Inc.
Jan 29, 2014
-
Insight Pharma Reports Announces Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
NEEDHAM, MA - Insight Pharma Reports announces Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor report. The newly released Insight Pharma Report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare.
Jan 29, 2014
-
Miltenyi Biotec Receives FDA Approval for CliniMACS® CD34 Reagent System for Prevention of Graft-Versus-Host Disease in the Treatment of Acute Myeloid Leukemia
BERGISCH GLADBACH, GERMANY - Miltenyi Biotec announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease (GVHD) in patients with acute myeloid leukemia (AML) in first complete remission undergoing allogeneic stem cell transplantation (SCT) from a matched related donor
Feb 25, 2014
-
Insight Pharma Reports Announces Digital PCR Technology Report: An Insight to Vendors, Costs & the End User Community
NEEDHAM, MA - Cambridge Healthtech Institute's Insight Pharma Reports announces Digital PCR Technology Report: An Insight to Vendors, Costs & the End User Community.
Nov 30, 2013